---
document_datetime: 2023-09-21 22:09:31
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/neulasta-epar-all-authorised-presentations_en.pdf
document_name: neulasta-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3629472
conversion_datetime: 2025-12-22 08:06:52.062358
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## (MA) EU number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

EU/1/02/227/001 Neulasta 6 mg Solution for injection Subcutaneous use pre-filled syringe (glass) 0.6 ml (10 mg/ml) 1 pre-filled syringe EU/1/02/227/002 Neulasta 6 mg Solution for injection Subcutaneous use pre-filled syringe (glass) without blister 0.6 ml (10 mg/ml) 1 pre-filled syringe EU/1/02/227/004 Neulasta 6 mg Solution for injection Subcutaneous use pre-filled syringe (glass) with needle guard 0.6 ml (10 mg/ml) 1 pre-filled syringe with needle guard